Skip to content
10-Q

Quarterly Report

Luckwel Pharmaceuticals Inc.

0001493152-21-022134

← back to feed
Filed
Sep 8, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2021 · Jul 31, 2021 147.16M sh
Operating Cash Flow Q2 2021 · Sep 30, 2020 −$13.07K
Operating Cash Flow Q2 2021 · Sep 30, 2019 −$170.02K
Cash And Equivalents Q2 2021 · Sep 30, 2020 $1.97K
Cash And Equivalents Q2 2021 · Mar 31, 2020 $44
Stockholders Equity Q2 2021 · Sep 30, 2020 −$1.47M
Stockholders Equity Q2 2021 · Jun 30, 2020 −$1.4M
Stockholders Equity Q2 2021 · Mar 31, 2020 −$1.33M
Stockholders Equity Q2 2021 · Sep 30, 2019 −$1.04M
Stockholders Equity Q2 2021 · Jun 30, 2019 −$932.34K
Stockholders Equity Q2 2021 · Mar 31, 2019 −$791.82K
Total Liabilities Q2 2021 · Sep 30, 2020 $1.48M
Total Liabilities Q2 2021 · Mar 31, 2020 $1.35M
Total Assets Q2 2021 · Sep 30, 2020 $12.32K
Total Assets Q2 2021 · Mar 31, 2020 $17.21K
Sga Expense Q2 2021 · Sep 30, 2020 $66.75K
Sga Expense Q2 2021 · Sep 30, 2020 $141.23K
Sga Expense Q2 2021 · Sep 30, 2019 $111.39K
Sga Expense Q2 2021 · Sep 30, 2019 $251.9K
Net Income Q2 2021 · Sep 30, 2020 −$67.01K
Net Income Q2 2021 · Sep 30, 2020 −$141.71K
Net Income Q2 2021 · Sep 30, 2019 −$111.39K
Net Income Q2 2021 · Sep 30, 2019 −$251.9K